Wild potato germplasm holds key to disease resistance
Wild potato germplasm that offers resistance to some major potato diseases has been identified by Agricultural Research Service (ARS) scientists. Geneticists Dennis Halterman and Shelley Jansky pinpointed the resistant wild potato species in studies at the ARS Vegetable Crops Research Unit in Madison, Wis.
Halterman has identified a wild potato species called Solanum verrucosum that contains a gene with resistance to late blight, considered the most destructive disease of potato. The wild species can be crossed with cultivated potatoes, and efforts are under way to move the late-blight resistance gene into the cultivated potato gene pool.
But the scientists aren't stopping there. They are using S. verrucosum to create a potato that's resistant to both late blight and early blight, a fungal disease that primarily affects the potato plant's leaves and stems but, if left uncontrolled, can lead to considerable reductions in yields.
To create the multi-disease-resistant cultivar, the scientists crossed S. verrucosum with another wild potato species that is resistant to early blight, and then crossed the wild potato hybrid with the cultivated potato. They currently have seedlings in the greenhouse waiting to be tested in the field.
Halterman and Jansky are also looking for resistance to Verticillium wilt, another fungal disease that can linger in the soil for up to 10 years. Halterman developed a molecular marker to screen potato germplasm for resistance against this disease, saving the scientists time and effort. They found resistance in the wild potato species S. chacoense and crossed it with the cultivated potato. According to Halterman, this could be a good, durable gene that may hold up over the long term.
Most read news
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Slim and potent - with side effects - Food supplements for weight loss or enhancing sexual performance can contain illegal active ingredients
EGene Inc. Announces Its Strategic Full-Service Distribution Alliance with AH Diagnostics of Denmark
Global Bioenergies announces break-through in direct biological production of butadiene
DSM receives grant of US Department of Energy for biotechnology research
Norwood_(charity)

Schizophrenia manifests itself in the brain structure - The symptoms of schizophrenia vary greatly from person to person

ImageBiopsy Lab - Wien, Austria
Eppendorf grows faster than the market
La Jolla Institute finds previous seasonal flu infections may provide some level of H1N1 immunity

Sequential antibiotic therapy in the laboratory and in patients - Rapid switching between different antibiotics could prevent the evolution of resistance and lead to successful treatment of patients
